FRIDAY, May 9, 2025 (HealthDay News) -- mRNA-1083 vaccine is noninferior and induces higher immune responses than recommended ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

"Supply and demand" constraints limit the body's ability to produce the various proteins needed for critical life functions, ...

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

As the field of personalized medicine evolves, digital technologies are playing a central role in revolutionizing cancer ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Cancer immunotherapy represents a transformative approach in oncology, especially for treating cancers thought to be incurable. However, a significant ...

Drug resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, occurring via secondary mutations or bypass pathways, is frequent among non-small-cell lung cancer patients.

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...

Scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines for ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

European leaders are actively courting American researchers with substantial financial incentives, viewing U.S. cuts to ...